DNA has often been likened to a book, with a set of instructions written in A’s, T’s, C’s, and G’s. But even if the contents of the book are known (which is increasingly the case as more and more genomes are sequenced), the where, when, or how loudly, the book is read is not known.

RNA-SeqSuch a graph was long a familiar sight to those interested in sequencing genes, but next generation technologies have come aboard, spurring developments like RNA-Seq. Image Credit: Wikimedia Commons.

After all, genes may be dormant, ferociously active, or anything in between. A gene’s transcription to RNA is influenced by the type of cell housing the gene, the stage of development of the organism, and the particular conditions that are currently encountered. So although sequencing a genome is certainly invaluable and informative, studying the transcriptome, the full set of all RNA molecules and their quantity in an organism, is crucial for studying genes in action and illuminating their relevance in development and disease.

RNA-Seq(uencing) is a relatively recent approach to documenting the transcriptome and has become a widely used tool in the biological community. It is an actively developing field with many different approaches, depending on the needs of the experiment. In general, however, RNA-Seq works by “reverse-transcribing” RNA in the lab to its DNA complement (known as “cDNA”), which is then fragmented into short sequences. (Alternatively, the RNA might be fragmented first, then reverse-transcribed.) Sequence adaptors are then added to the ends of the cDNA fragments, and then they are ready for their sequences to be read [1].

This brings us to why RNA-Seq is somewhat of a newcomer. The demand for sequencing that can be performed quickly and at low cost drove the development of new, next generation technologies that hold advantages over the traditional method. Various novel methods allow many sequences to analyzed concurrently. This enables, to a high degree of accuracy, the multiple reading of the same section of DNA (“deep sequencing”). With this technology now on the scene, it has become more feasible to sequencing all the cDNA that comes with reverse transcribing RNA from cells. In fact, this high demand for RNA-Seq and other sequencing methods are illustrated through the many vendors at Assay Depot that offer expertise in next generation sequencing.

RNA-Seq boasts several favorable properties. For one,  the genome sequence of the species does not have to be known, a plus for researchers working with organisms a bit off the beaten path. Another bonus is that the background signal is low to non-existent. There is no worry of reaching an upper limit either, and as a result, transcripts can be measured in a range spanning as many as five orders of magnitude [2]. The clarity of RNA-Seq also means that person-to-person variability in transcript composition can often be picked up.

These desirable features and more are cause for the current intense interest in RNA-Seq. The dynamic transcriptome in all its variation means that genes are no simple book to be read, but RNA-Seq helps with the comprehension.

References

1. Wang, Z. et al. (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10:57-63.

2. Mortazavi et al. (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5:621-628.

Posted 8:00 am,

Outsourcing drug discovery and development has become the key to making the entire drug research process more efficient. Over the past few years, pharmaceutical companies have realized their current format of doing all work in-house is unsustainable, given the constant challenge to reduce costs and increase efficiency. They have suffered decreased productivity, higher costs, and […]

Read More...
Posted 8:00 pm,

We recently talked about how Green Fluorescent Protein, restriction enzymes, and CRISPR are invaluable products of basic research. These investigations did not specifically go after a particular human ailment or disease, but were more directed towards enhancing our understanding of the world. These examples are just a few of the famous outcomes of basic research, […]

Read More...
Posted 8:00 pm,

The Fermanian School of Business and the Fermanian Business and Economic Institute held their annual Business Breakfast honoring the Dealmakers of the Year for 2014 on April 10th. These awards recognize individuals, firms, and collaborations that exemplify creativity, innovation, and ethical practices that create long term value for the business community in the San Diego […]

Read More...
Posted 8:00 pm,

Over the course of the last century we’ve had the age of antibiotics, the genetic revolution, transplantation and immunotherapy, each of which ushered in a raft of new therapies dramatically improving human health.  Now we enter the “Age of the Microbiome” in drug discovery, the scope of which potentially exceeds anything that has gone before […]

Read More...
Posted 8:15 am,

We invited Bob Evans, Senior Business Development & Marketing Director from one of our most trusted vendors Cambridge Biomedical to discuss onshoring versus offshoring and why you choose a domestic CRO for your bioanalytical assay needs? Offshoring is a term often heard within the CRO community from clients who seek to find the lowest cost […]

Read More...
Posted 8:00 pm,

There’s a new trend in the biotech startup world, and that’s the increasing presence of biotech startup incubators across the country. Many scientists are moving away from the large pharmaceutical companies, whether as a result of job layoffs or their desire to work in a smaller company setting, and are grouping together with new exciting […]

Read More...
Posted 8:00 pm,

Assay Depot released a press release announcing it raised $3 million in Series B Funds to “Grow Science as a Server” Platform. Assay Depot is often referred to as the “Amazon.com for scientists” and hopes to increase drug discovery efficiency. That way, scientists are able to “outsource everything but the genius” and spend their time […]

Read More...
Posted 8:00 pm,

Whenever it is announced that budgets must be tightened, it is often scientists performing basic research who are among the first to be called to justify their financial support. Everyone can usually agree that investigating a promising cancer or disease treatment deserves funding, but when it comes to a basic research program, an exploration of […]

Read More...
Posted 8:00 pm,

The increasing awareness of the scientific research community on the importance of open access and open science has given rise to a new funding source in the research world. While the rise of start-ups and the popularity of the start-up culture have given rise to crowdfunding, open access to scientific data has also aided the […]

Read More...
Posted 8:00 pm,